{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:50:11Z","timestamp":1773888611252,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["14140903802"],"award-info":[{"award-number":["14140903802"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.biopha.2016.09.091","type":"journal-article","created":{"date-parts":[[2016,10,2]],"date-time":"2016-10-02T17:16:25Z","timestamp":1475428585000},"page":"674-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Annexin A2, up-regulated by IL-6, promotes the ossification of ligament fibroblasts from ankylosing spondylitis patients"],"prefix":"10.1016","volume":"84","author":[{"given":"Da-He","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Ru","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9313","key":"10.1016\/j.biopha.2016.09.091_bib0005","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2016.09.091_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jbspin.2011.09.008","article-title":"Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models","volume":"79","author":"Braem","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.biopha.2016.09.091_bib0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jbspin.2010.09.010","article-title":"Correlations among clinical, radiographic, and sonographic scores for enthesitis in ankylosing spondylitis","volume":"78","author":"Hamdi","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.biopha.2016.09.091_bib0020","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3892\/etm.2013.1349","article-title":"Effects of hypoxia on the proliferation, mineralization and ultrastructure of human periodontal ligament fibroblasts","volume":"6","author":"Zhang","year":"2013","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.biopha.2016.09.091_bib0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrm1661","article-title":"Annexins: linking Ca2+ signalling to membrane dynamics","volume":"6","author":"Gerke","year":"2005","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2016.09.091_bib0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1050-1738(99)00020-1","article-title":"Annexin II: a mediator of the plasmin\/plasminogen activator system","volume":"9","author":"Hajjar","year":"1999","journal-title":"Trends Cardiovasc. Med."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2016.09.091_bib0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1242\/jcs.105.2.533","article-title":"Involvement of annexin II in DNA replication: evidence from cell-free extracts of Xenopus eggs","volume":"105","author":"Vishwanatha","year":"1993","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.biopha.2016.09.091_bib0040","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1074\/jbc.M806499200","article-title":"Annexin A2 binding to endosomes and functions in endosomal transport are regulated by tyrosine 23 phosphorylation","volume":"284","author":"Morel","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2016.09.091_bib0045","first-page":"1157","article-title":"Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma","volume":"33","author":"Mohammad","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.091_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12185-009-0356-8","article-title":"Overexpression of annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma","volume":"90","author":"Bao","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.091_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6605128","article-title":"Annexin II represents metastatic potential in clear-cell renal cell carcinoma","volume":"101","author":"Ohno","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2016.09.091_bib0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yexmp.2006.03.003","article-title":"Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression","volume":"81","author":"Sharma","year":"2006","journal-title":"Exp. Mol. Pathol."},{"issue":"7","key":"10.1016\/j.biopha.2016.09.091_bib0065","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/gut.2003.026831","article-title":"Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro","volume":"53","author":"Diaz","year":"2004","journal-title":"Gut"},{"issue":"40","key":"10.1016\/j.biopha.2016.09.091_bib0070","doi-asserted-by":"crossref","first-page":"14346","DOI":"10.1523\/JNEUROSCI.3299-11.2011","article-title":"Annexin A2 promotes glioma cell invasion and tumor progression","volume":"31","author":"Zhai","year":"2011","journal-title":"J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2016.09.091_bib0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1242\/jcs.00909","article-title":"The role of annexin 2 in osteoblastic mineralization","volume":"117","author":"Gillette","year":"2004","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.biopha.2016.09.091_bib0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jcp.24123","article-title":"Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis","volume":"228","author":"Kim","year":"2013","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.091_bib0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10067-006-0283-5","article-title":"Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis","volume":"26","author":"Bal","year":"2007","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2016.09.091_bib0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/ard.53.6.425-b","article-title":"Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis","volume":"53","author":"Tutuncu","year":"1994","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2016.09.091_bib0095","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/rheumatology\/33.10.927","article-title":"Serum cytokines (IL-6, TNF-alpha IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity","volume":"33","author":"Gratacos","year":"1994","journal-title":"Br. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2016.09.091_bib0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1349-7006.2006.00197.x","article-title":"Signal transduction of inflammatory cytokines and tumor development","volume":"97","author":"Yoshimura","year":"2006","journal-title":"Cancer Sci."},{"issue":"29","key":"10.1016\/j.biopha.2016.09.091_bib0105","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1016\/j.biomaterials.2011.06.003","article-title":"The stimulation of osteogenic differentiation of human adipose-derived stem cells by ionic products from akermanite dissolution via activation of the ERK pathway","volume":"32","author":"Gu","year":"2011","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.biopha.2016.09.091_bib0110","doi-asserted-by":"crossref","first-page":"9645","DOI":"10.1074\/jbc.275.13.9645","article-title":"Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase","volume":"275","author":"Jaiswal","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.091_bib0115","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1091\/mbc.e04-08-0695","article-title":"Laminin-5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK-dependent pathway","volume":"16","author":"Klees","year":"2005","journal-title":"Mol. Biol. Cell"},{"issue":"7","key":"10.1016\/j.biopha.2016.09.091_bib0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1006\/cyto.1997.0325","article-title":"IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein","volume":"10","author":"Solito","year":"1998","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.biopha.2016.09.091_bib0125","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.4049\/jimmunol.177.11.8148","article-title":"Annexin 1 negatively regulates IL-6 expression via effects on p38 MAPK and MAPK phosphatase-1","volume":"177","author":"Yang","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2016.09.091_bib0130","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.0804000","article-title":"Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper","volume":"183","author":"Yang","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2016.09.091_bib0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ijc.23928","article-title":"Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells","volume":"124","author":"Inokuchi","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2016.09.091_bib0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.biopha.2016.09.091_bib0145","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2016.09.091_bib0150","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"issue":"53","key":"10.1016\/j.biopha.2016.09.091_bib0155","doi-asserted-by":"crossref","first-page":"37620","DOI":"10.1074\/jbc.274.53.37620","article-title":"The annexin protein lipocortin 1 regulates the MAPK\/ERK pathway","volume":"274","author":"Alldridge","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2016.09.091_bib0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-4827(03)00310-0","article-title":"Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1\/2 MAPK signal","volume":"290","author":"Alldridge","year":"2003","journal-title":"Exp. Cell. Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216309192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216309192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:32:22Z","timestamp":1773873142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216309192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":32,"alternative-id":["S0753332216309192"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.09.091","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annexin A2, up-regulated by IL-6, promotes the ossification of ligament fibroblasts from ankylosing spondylitis patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.09.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}